HLA supertypes and immune responses to measles-mumps-rubella viral vaccine: Findings and implications for vaccine design

Vaccine

Volumn 25, Issue 16 SPEC. ISS., 2007, Pages 3090-3100

  Ovsyannikova, Inna G ^a   Jacobson, Robert M ^a,b   Vierkant, Robert A ^b   Pankratz, V Shane ^b   Poland, Gregory A ^a,b  

^a Mayo Vaccine Research Group   (United States)

^b Mayo Clinic   (United States)

Author keywords

HLA supertypes; Immunity; MMR vaccine

Indexed keywords

EPITOPE; HLA A3 ANTIGEN; HLA ANTIGEN; HLA B44 ANTIGEN; HLA B58; HLA B62; HLA B7 ANTIGEN; HLA DR ANTIGEN; MEASLES MUMPS RUBELLA VACCINE; UNCLASSIFIED DRUG; VIRUS VACCINE;

ADOLESCENT; ADULT; ALLELE; ARTICLE; CELLULAR IMMUNITY; CHILD; ENGINEERING; FEMALE; HLA TYPING; HUMAN; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNIZATION; INFORMATION; MALE; MEASLES; MUMPS; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 33947587192     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2007.01.020     Document Type: Article

References (28)

1. Poland G.A., and Jacobson R.M. The genetic basis for variation in antibody response to vaccines. Curr Opin Pediatr 10 (1998) 208-215
2. Bautista-López N., Ward B.J., Mills E., McCormick D., Martel N., and Ratnam S. Development and durability of measles antigen-specific lymphoproliferative response after MMR vaccination. Vaccine 18 (2000) 1393-1401
3. Ovsyannikova I.G., Pankratz S.V., Vierkant R., Jacobson R.M., and Poland G.A. Human leukocyte antigen haplotypes in the genetic control of immune response to measles-mumps-rubella vaccine. J Infect Dis 193 5 (2006) 655-663
4. Sidney J., del Guercio M.F., Southwood S., Engelhard V.H., Appella E., Rammensee H.J., et al. Several HLA alleles share overlapping peptide specificities. J Immunol 154 1 (1995) 247-259
5. Sette A., and Sidney J. HLA supertypes and supermotifs: a functional perspective on HLA polymorphism. Curr Opin Immunol 10 (1998) 478-482
6. Southwood S., Sidney J., Kondo A., del Guercio M.F., Appella E., Hoffman S., et al. Several common HLA-DR types share largely overlapping peptide binding repertoires. J Immunol 160 7 (1998) 3363-3373
7. Sidney J., Southwood S., Mann D.L., Fernandez-Vina M.A., Newman M.J., and Sette A. Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. Hum Immunol 62 11 (2001) 1200-1216
8. Sette A., and Sidney J. Nine major HLA class I supertypes account for the vast preponderance of HLA-A and -B polymorphism. Immunogenetics 50 3-4 (1999) 201-212
9. Sette A., Sidney J., Livingston B.D., Dzuris J.L., Crimi C., Walker C.M., et al. Class I molecules with similar peptide-binding specificities are the result of both common ancestry and convergent evolution. Immunogenetics 54 12 (2003) 830-841
10. Ou D., Mitchell L.A., and Tingle A.J. A new categorization of HLA DR alleles on a functional basis. Hum Immunol 59 (1998) 665-676
11. Ovsyannikova I.G., Jacobson R.M., Vierkant R.A., Jacobsen S.J., Pankratz V.S., and Poland G.A. The contribution of HLA class I antigens in immune status following two doses of rubella vaccination. Hum Immunol 65 (2004) 1506-1515
12. + T cells in subjects seronegative or highly seropositive for measles vaccine. Clin Diag Lab Immunol 10 3 (2003) 411-416
13. Gans H.A., Maldonado Y., Yasukawa L.L., Beeler J., Audet S., Rinki M.M., et al. IL-12, IFNγ, and T cell proliferation to measles in immunized infants. J Immunol 162 (1999) 5569-5575
14. Ovsyannikova I.G., Jacobson R.M., Ryan J.E., Vierkant R.A., Pankratz V.S., and Poland G.A. HLA class II alleles and measles virus-specific cytokine immune response following two doses of measles vaccine. Immunogenetics 56 (2005) 798-807
15. Dhiman N., Ovsyannikova I.G., Howe R.C., Ryan J.E., Jacobson R.M., and Poland G.A. Interleukin-4 induced by measles virus and measles-derived peptides as measured by IL-4 receptor-blocking ELISA. J Immunol Methods 287 1-2 (2004) 217-225
16. Ovsyannikova I.G., Jacobson R.M., Vierkant R.A., Jacobsen S.J., Pankratz V.S., and Poland G.A. Human leukocyte antigen class II alleles and rubella-specific humoral and cell-mediated immunity following measles-mumps-rubella-II vaccination. J Infect Dis 191 4 (2005) 515-519
17. Sidney J., Southwood S., del Guercio M.F., Grey H.M., Chesnut R.W., Kubo R.T., et al. Specificity and degeneracy in peptide binding to HLA-B7-like class I molecules. J Immunol 157 8 (1996) 3480-3490
18. Spielberg S.P. Therapeutics and toxicology. Curr Opin Pediatr 10 (1998) 201-202
19. Trachtenberg E., Korber B., Sollars C., Kepler T.B., Hraber P.T., Hayes E., et al. Advantage of rare HLA supertype in HIV disease progression. Nat Med 9 7 (2003) 928-935
20. Doolan D.L., Hoffman S.L., Southwood S., Wentworth P.A., Sidney J., Chesnut R.W., et al. Degenerate cytotoxic T cell epitopes from P. falciparum restricted by multiple HLA-A and HLA-B supertype alleles. Immunity 7 (1997) 97-112
21. MacDonald K.S., Kimani J., Dunand V.A., Nagelkerke N.J.D., Ball T.B., Oyugi J., et al. Influence of HLA supertypes on susceptibility and resistance to human immunodeficiency virus type 1 infection. J Infect Dis 181 1581 (2000) 1589
22. Burrows S.R., Elkington R.A., Miles J.J., Green K.J., Walker S., Haryana S.M., et al. Promiscuous CTL recognition of viral epitopes on multiple human leukocyte antigens: biological validation of the proposed HLA A24 supertype. J Immunol 171 3 (2003) 1407-1412
23. Bertoni R., Sidney J., Fowler P., Chesnut R.W., Chisari F.V., and Sette A. Human histocompatibility leukocyte antigen-binding supermotifs predict broadly cross-reactive cytotoxic T lymphocyte responses in patients with acute hepatitis. J Clin Invest 100 3 (1997) 503-513
24. Huczko E.L., Bodnar W.M., Benjamin D., Sakaguchi K., Zhu N.Z., Shabanowitz J., et al. Characteristics of endogenous peptides eluted from the class I MHC molecule HLA-B7 determined by mass spectrometry and computer modeling. J Immunol 151 (1993) 2572-2587
25. Sidney J., Southwood S., and Sette A. Classification of A1- and A24-supertype molecules by analysis of their MHC-peptide binding repertoires. Immunogenetics 57 6 (2005) 393-408
26. Bodmer J.G., Marsh S.G.E., Albert E.D., et al. Nomenclature for factors of the HLA system, 1995. Tissue Antigens 46 (1995) 1-18
27. Sidney J., Grey H.M., Kubo R.T., and Sette A. Practical, biochemical and evolutionary implications of the discovery of HLA class I supermotifs. Immunol Today 17 6 (1996) 261-266
28. Rammensee H.-G., Friede T., and Stevanovic S. MHC ligands and peptide motifs: first listing. Immunogenetics 41 (1995) 178-228